Cannabis genetics are the industry's greatest asset - and most fragile

Mr. Sherbinski, a prominent cannabis breeder, warns that the industry is still using outdated methods to protect its most valuable asset: genetics. While cultivation facilities and HVAC systems can be replaced, elite cultivars represent years of breeding and refinement that vanish instantly if lost to pests or disease. Relying solely on mother plants in a grow room is an obsolete strategy that exposes companies to significant financial risk.

In the early years, breeders like Sherbinski dealt with raids and mites, but today the threat comes from systemic issues like hop latent viroid. These biological threats can wipe out a library of genetics before a facility manager even identifies the problem. Because of this, Sherbinski argues that genetic preservation is now an essential business investment rather than a luxury.

He points to tissue culture as the standard for securing long-term viability. By initiating genetics into a tissue culture environment, breeders lock in the health and purity of their plants, shielding them from the degradation that happens over time with aging mother plants. This process provides a hedge against environmental failure and biological contamination.

For companies that do not want to build their own labs, partnering with established tissue culture facilities offers a practical path forward. These partnerships often allow for creative arrangements where the breeder secures their genetic library in exchange for access to exclusive breeding material. As the market matures, companies that prioritize the security of their proprietary genetics will distinguish themselves as the leaders of the next generation.